NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Health Information Services · USD

Carlsmed, Inc. (CARL) Stock Analysis

Carlsmed, Inc. (CARL) is a Health Information Services stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

CARL

$14.31

+$0.13 (+0.92%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare CARL with… →

CARL Key Statistics

As of Oct 21, 2026
Trading
Open
$14.17
Previous Close
$14.18
Day's Range
14.16–14.99
52-Week Range
8.50–17.23
Volume
129.32K
Valuation
Market Cap
$395.07M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
6.24
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.08
Financials (FY)
Revenue (FY)
$50.51M+85.94%
Net Income (FY)
−$29.63M
Profit marginThe share of revenue left as profit after all costs and taxes.
−57.42%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
27.30M
1-Year Return
+1.49%
Dividend and dates
Earnings Date
November 5, 2026estimated
Avg Volume
122.67K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, CARL closed at $14.31, +1.49% over 1 year.

Carlsmed, Inc. (CARL) has a market capitalization of $395.07M.

In fiscal 2025, CARL reported revenue of $50.51M.

CARL Stock Return by Calendar Year

Carlsmed, Inc. (CARL) return since Jul 2025: what $10,000 became

1 year
$10,000 $10,149
+1.49%
Since Jul 2025
$10,000 $9,869
−1.31%

If you had invested $10,000 in Carlsmed, Inc. (CARL) at the close on July 23, 2025, the earliest close on record here, it would have been worth $9,869 at the close on October 21, 2026: −1.31% in total, −1.05% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+15.87%
2025 (partial year)−14.83%

As of October 21, 2026.

CARL Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$50.51M−$29.63M−58.7%
2024$27.17M−$24.26M−89.3%
2023$13.78M−$18.90M−137.2%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$50.51M$38.04M−$30.57M−$29.63M−58.7%
2024$27.17M$20.05M−$24.12M−$24.26M−89.3%
2023$13.78M$9.90M−$18.59M−$18.90M−137.2%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

CARL Valuation vs Health Information Services Median

Median of 44 stocks
MetricCARLHealth Information Services medianvs median
P/S ratio6.242.31171% above
Profit margin−57.42%−7.55%49.9 pts below

Medians across 44 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 16 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Carlsmed, Inc. (CARL) carries a market capitalisation of $395.07M. It is classified in the Health Information Services industry, within the Healthcare sector. The company reports 127 employees.

The most recent close on file for CARL is $14.31, dated October 21, 2026. That is +$0.13 (+0.92%) against the previous close. The 52-week range on file runs from $8.50 to $17.23. The latest close sits 68.35% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $50.51M. Against the prior fiscal year total of $27.17M, that is a change of +85.94%. The same year closed with a net loss of $29.63M. The reported profit margin is −57.42%. That is 49.9 percentage points below the Health Information Services median of −7.55%. Earnings per share on a trailing basis come to −1.08.

Across the 3 fiscal years on file, revenue moves from $13.78M in 2023 to $50.51M in 2025. Of those 3 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 6.24 times revenue. On price-to-sales that is 170.64% above the Health Information Services median of 2.31. 44 Health Information Services companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the total return is +1.49%. Daily returns over the trailing 1 year annualize to a volatility of 71.04%.

Growth & Income

No dividend is on file for CARL.

So far in 2026 the total return is +15.87%.

Peer Comparison

Carlsmed, Inc. (CARL) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Carlsmed, Inc. CARL $395.07M —
Veeva Systems Inc. VEEV $51.90B 52.6
BrightSpring Health Services, Inc. BTSG $12.40B 55.4
Tempus AI, Inc. TEM $12.23B —

The Health Information Services industry average P/E ratio is 46.5x. Carlsmed, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Health Information Services Stocks

VEEV

Veeva Systems Inc.

$51.90B

 BTSG

BrightSpring Health Services, Inc.

$12.40B

 TEM

Tempus AI, Inc.

$12.23B

 HNGE

Hinge Health, Inc.

$9.04B

 HQY

HealthEquity, Inc.

$8.10B

 DOCS

Doximity, Inc.

$5.99B
View all Health Information Services stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Carlsmed, Inc.

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Visit website →